{"id":"https://genegraph.clinicalgenome.org/r/2c1fd017-b4d6-4fe0-9f07-1c86ab1d7562v1.0","type":"EvidenceStrengthAssertion","dc:description":"Intragenic deletions in MED13L were first reported in patients with syndromic intellectual disability in 2013 (Asadollahi et al., PMID: 23403903). Individuals with loss-of-function (LoF) variants in MED13L present with moderate to severe intellectual disability, muscular hypotonia and facial anomalies (PMIDs: 28645799, 29511999). Additional features observed in 20%-50% of patients include severe speech delay, abnormal brain MRI, ataxia, and autistic features; cardiac anomalies have been reported in about 17% of patients (PMIDs: 28645799, 29511999). De novo LoF variants, including large intragenic deletions, nonsense, frameshift and splice site variants have been reported in over 30 probands in 5 publications (PMIDs: 23403903, 24781760, 25712080, 27500536, 29511999). Other individuals with MED13L variants have been reported in the literature, but they were not included in this curation since the maximum score for genetic evidence had been reached. At least 13 individuals with de novo missense variants presented with similar but more severe phenotypes and with a higher frequency of seizures than observed in patients with LoF variants (PMIDs: 32646507, 24896178, 27500536, 28645799, 29593475, 29511999). Probands with a missense variant were not counted towards genetic evidence since functional data supporting pathogenicity of missense variants was not available. The mechanism of disease is haploinsufficiency of MED13L (PMIDs: 23403903, 25137640). The gene-disease relationship is supported by a model organism, rescue experiments, protein interaction, and biochemical function data. In summary, MED13L is definitively associated with autosomal dominant syndromic intellectual disability (PMID: 29209056). The classification was approved by the ClinGen Intellectual Disability and Autism Gene Curation Expert Panel on 04/21/21 (SOP Version 8).","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/2c1fd017-b4d6-4fe0-9f07-1c86ab1d7562","GCISnapshot":"https://genegraph.clinicalgenome.org/r/41758f8d-1f99-47fa-beb6-c327fa6cb940","calculatedEvidenceStrength":"Definitive","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/41758f8d-1f99-47fa-beb6-c327fa6cb940_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10006","date":"2021-06-10T01:27:57.272Z","role":"Publisher"},{"id":"https://genegraph.clinicalgenome.org/r/41758f8d-1f99-47fa-beb6-c327fa6cb940_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10006","date":"2021-04-21T04:00:00.000Z","role":"Approver"}],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/41758f8d-1f99-47fa-beb6-c327fa6cb940_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/41758f8d-1f99-47fa-beb6-c327fa6cb940_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1f75d243-eb23-450c-9192-b2a6934530d4","type":"EvidenceLine","dc:description":"Downgraded since morpholino knockdown was used, therefore, nonspecific targeting of other genes is not ruled out. Later experiments showed that phenotypes observed in morpholino knockdown embryos were rescued by human MED13L expression, so only downgraded by 0.5pts.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1b314e5b-ac07-45c9-b254-a552f3a25dd8","type":"Finding","dc:description":"Craniofacial cartilage defects upon disruption of med13b are consistent with craniofacial abnormalities observed in individuals with MED13L haploinsufficiency.  \nImpact of med13b in neuronal development suggests abnormal neuronal development may explain intellectual disability in patients with MED13L mutation\n","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25137640","rdfs:label":"Zebrafish med13b (ortholog of MED13L) knockdown model","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/8127f2df-3de6-47e1-bd9d-98d8f4dc030f","type":"EvidenceLine","dc:description":"Expression of human MED13L mRNA did not full rescue all phenotypes observed in med13b knockdown embryos. med13b morpholino off target effect is not ruled out, therefore score is downgraded.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/adcd3873-8bc0-41e3-a5fd-d22402bb3ba3","type":"Finding","dc:description":"Coinjection of full-length human MED13L mRNA with med13b MO was sufficient to rescue the eye size of the morphants, and fully restore head development.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25137640","rdfs:label":"Rescue of med13b knockdown phenotypes with human MED13L mRNA","demonstrates":{"id":"cg:PhenotypeRescue"}}],"specifiedBy":"GeneValidityNonHumanRescueCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":2.5},{"id":"https://genegraph.clinicalgenome.org/r/41758f8d-1f99-47fa-beb6-c327fa6cb940_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9f5babe3-9a34-45e7-9de3-1f4fa9b82cf2","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/eee9b073-4245-403c-b754-ec384fd0629e","type":"Finding","dc:description":"Several genes encoding for protein subunits of the mediator complex, including CDK8, MED12 and MED13 are associated with intellectual disability when mutated. These proteins are part of the mediator kinase module, required for biochemical function of the mediator complex that functions as a transcriptional coactivator of RNA polymerase II- transcribed genes. ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23322298","rdfs:label":"MED13L functions as a transcriptional coactivator","demonstrates":{"id":"cg:BiochemicalFunctionA"}}],"specifiedBy":"GeneValidityBiochemicalFunctionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/83683b5f-7fac-4e2e-88aa-6e61e6d0096b","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/77dec81e-b5f7-4a98-99de-56ca775f04e1","type":"Finding","dc:description":"MED13L co-immunoprecipitate with proteins associated with intellectual disability: MED13, MED12  and CDK8. \n\nMED13L is a component of the Mediator complex, which functions as a regulator for gene transcription. Specifically, MED13L is a subunit of the Mediator kinase module. Mutations in genes that encode other subunits of the Mediator kinase module are associated with ID, ASD and epileptic encephalopathy, including MED12, MED12L, MED13, CDK8, and CDK19. Other components of the mediator complex are also involved in ID, including MED17, MED23, and MED25 (PMID:Â 29209056).","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23322298","rdfs:label":"MED13L protein interaction","demonstrates":{"id":"obo:MI_0915"}}],"specifiedBy":"GeneValidityProteinInteractionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":3.5},{"id":"https://genegraph.clinicalgenome.org/r/41758f8d-1f99-47fa-beb6-c327fa6cb940_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/41758f8d-1f99-47fa-beb6-c327fa6cb940_ad_dn_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ad59187b-809f-431b-b58c-985c9a4f08ea_proband_score_evidence_line","type":"EvidenceLine","dc:description":"variant is identified by targeted sequencing of MED13L. Exome sequencing was not perform and possibility of other causative variant is not ruled out. Downgraded by only 0.5 pts since patient phenotype is highly consistent with MED13L related syndromic intellectual disability.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9f088da3-2e93-40e6-b7d9-a507e98a9367","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25712080","rdfs:label":"Patient 2","ageUnit":"Years","ageValue":3,"detectionMethod":"Targeted MED13 sequencing","firstTestingMethod":"Genotyping","phenotypes":["obo:HP_0005280","obo:HP_0000664","obo:HP_0011343","obo:HP_0000341","obo:HP_0000414","obo:HP_0011800","obo:HP_0011228","obo:HP_0000582","obo:HP_0002002","obo:HP_0000303","obo:HP_0000248","obo:HP_0011171","obo:HP_0002263","obo:HP_0000286","obo:HP_0001655","obo:HP_0000565","obo:HP_0000348","obo:HP_0040080"],"sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/ad59187b-809f-431b-b58c-985c9a4f08ea_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25712080","allele":{"id":"https://genegraph.clinicalgenome.org/r/19221622-6811-418e-a7e4-bd4267b08bd8","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_015335.4(MED13L):c.607dup (p.Ser203fs)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA351504"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes"}}],"specifiedBy":"GeneValidityProbandADDeNovoCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/a60d9415-fbb8-4857-8649-641e9fd64531_proband_score_evidence_line","type":"EvidenceLine","dc:description":"RNA study showed deletion of 15 amino acids in the conserved N-terminal domain.\n","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f80dc73b-e655-40bf-b512-80492918ad12","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24781760","rdfs:label":"Patient 1","ageUnit":"Years","ageValue":3,"detectionMethod":"Trio wes","firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0002558","obo:HP_0000324","obo:HP_0000158","obo:HP_0005280","obo:HP_0000194","obo:HP_0000750","obo:HP_0000347","obo:HP_0001276","obo:HP_0000582","obo:HP_0010862"],"sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/a60d9415-fbb8-4857-8649-641e9fd64531_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24781760","allele":{"id":"https://genegraph.clinicalgenome.org/r/b37af5de-4052-4bec-bcbc-7af12c3826c8","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_015335.4(MED13L):c.480-1G>T","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA351519"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes"}}],"specifiedBy":"GeneValidityProbandADDeNovoCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/8ce5aacf-bd90-4eb5-9578-6c622ebb7828_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5f86e75d-c755-4579-b29b-fffdb8173f8d","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25712080","rdfs:label":"Patient 1","ageUnit":"Years","ageValue":8,"firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0006863","obo:HP_0001762","obo:HP_0005280","obo:HP_0001290","obo:HP_0000527","obo:HP_0000175","obo:HP_0011800","obo:HP_0011343","obo:HP_0000219","obo:HP_0011228","obo:HP_0000348","obo:HP_0002066","obo:HP_0000248","obo:HP_0000303"],"sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/8ce5aacf-bd90-4eb5-9578-6c622ebb7828_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25712080","allele":{"id":"https://genegraph.clinicalgenome.org/r/9f4d7681-564c-4009-ad32-001ec62ef4dd","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_015335.4(MED13L):c.3765del (p.Cys1256fs)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA351563"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes"}}],"specifiedBy":"GeneValidityProbandADDeNovoCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/61b92848-68db-4bdf-955a-cd1e428a2fc7_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/50c2a7e5-527c-43b6-89de-245305e181ee","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29511999","rdfs:label":"Patient 7","ageUnit":"Years","ageValue":4,"detectionMethod":"ID panel","firstTestingMethod":"Next generation sequencing panels","phenotypes":["obo:HP_0000750","obo:HP_0001181","obo:HP_0000414","obo:HP_0002002","obo:HP_0002263","obo:HP_0001270","obo:HP_0002342","obo:HP_0000194"],"sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/61b92848-68db-4bdf-955a-cd1e428a2fc7_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29511999","allele":{"id":"https://genegraph.clinicalgenome.org/r/a3b93dbc-5dfb-4e4e-84b0-400ac9041db5","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_015335.4(MED13L):c.1704_1705AG[2] (p.Ser570fs)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA351557"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes"}}],"specifiedBy":"GeneValidityProbandADDeNovoCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/278f13f1-d7d8-44d4-adb8-a03a630714d2_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f19a1612-5701-409f-bf11-7c8600b4f74f","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25712080","rdfs:label":"Patient 3","ageType":"AgeAtReport","ageUnit":"Years","ageValue":12,"firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0000158","obo:HP_0000286","obo:HP_0011343","obo:HP_0001250","obo:HP_0000303","obo:HP_0005280","obo:HP_0011220","obo:HP_0009890","obo:HP_0000582","obo:HP_0002007","obo:HP_0000414","obo:HP_0004467","obo:HP_0000256"],"sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/278f13f1-d7d8-44d4-adb8-a03a630714d2_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25712080","allele":{"id":"https://genegraph.clinicalgenome.org/r/7f3dda9e-3fbe-477d-8f1e-db54c98184fe","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_015335.5(MED13L):c.4420A>T (p.Lys1474Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA386883682"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes"}}],"specifiedBy":"GeneValidityProbandADDeNovoCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/d15c8ece-f779-41e1-95c4-71653288f10e_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/48616fe3-0213-48e0-994c-8f92da1820f9","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27500536","rdfs:label":"Patient 3","ageUnit":"Years","ageValue":24,"detectionMethod":"Targeted sequencing of 1,256 NDD genes and CMA","firstTestingMethod":"Next generation sequencing panels","phenotypes":["obo:HP_0000369","obo:HP_0005280","obo:HP_0000414","obo:HP_0001256","obo:HP_0000347","obo:HP_0000294","obo:HP_0000286","obo:HP_0000189","obo:HP_0000303","obo:HP_0001263","obo:HP_0001252","obo:HP_0002007","obo:HP_0002370","obo:HP_0000494"],"sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/d15c8ece-f779-41e1-95c4-71653288f10e_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27500536","allele":{"id":"https://genegraph.clinicalgenome.org/r/2a491f98-e672-4e4a-a6c9-cfd905e84ab3","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_015335.4(MED13L):c.2524C>T (p.Arg842Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA16619445"}},"paternityMaternityConfirmed":"none"}}],"specifiedBy":"GeneValidityProbandADDeNovoCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallAutosomalDominantDeNovoVariantEvidenceCriteria","strengthScore":11.5}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":11.5}],"evidenceStrength":"Definitive","sequence":2893,"specifiedBy":"GeneValidityCriteria8","strengthScore":15,"subject":{"id":"https://genegraph.clinicalgenome.org/r/UccfJR4VSCE","type":"GeneValidityProposition","disease":"obo:MONDO_0000508","gene":"hgnc:22962","modeOfInheritance":"obo:HP_0000006"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_41758f8d-1f99-47fa-beb6-c327fa6cb940-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}